Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Frampton

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Accident; Analysis and Prevention|December 1, 1995
Appropriate frontal barrier tests for belted occupantsJ R Hill, R J Frampton, M Mackay
Endocrinology|March 1, 1985
Regulation of the 1,25-dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cellsE Sher, R J Frampton, J A Eisman
Biology of the Neonate|January 1, 1990
Effect on the fetus of infusing a commercial amino acid preparation into a pregnant sheepR A MacMahon, R J Frampton, R W Yardley
Cell Biochemistry and Function|April 1, 1986
Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell linesJ A Eisman, R J Frampton, F J McLean
Biology of the Neonate|January 1, 1986
Changes in plasma amino acids in the developing chickR J Frampton, R W Yardley, R A MacMahon
The Australian and New Zealand Journal of Surgery|February 1, 1984
1,25-dihydroxyvitamin D3 and breast cancerJ A Eisman, L J Suva, R J Frampton
Cancer Research|September 1, 1983
Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolitesR J Frampton, S A Omond, J A Eisman
The Journal of Endocrinology|July 1, 1991
Increased secretion of insulin-like growth factor-binding proteins and decreased secretion of insulin-like growth factor-II by muscle from growth-retarded neonatal ratsR J Frampton, H A Jonas, R G Larkins
Journal of Developmental Physiology|March 1, 1990
Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal ratsR J Frampton, H A Jonas, R A MacMahon, et al.
Clinical Endocrinology|September 1, 1980
Normal and malignant breast tissue is a target organ for 1,25-(0H)2 vitamin D3J A Eisman, I Macintyre, T J Martin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Accident; Analysis and Prevention|December 1, 1995
Appropriate frontal barrier tests for belted occupantsJ R Hill, R J Frampton, M Mackay
Endocrinology|March 1, 1985
Regulation of the 1,25-dihydroxyvitamin D3 receptor by 1,25-dihydroxyvitamin D3 in intact human cancer cellsE Sher, R J Frampton, J A Eisman
Biology of the Neonate|January 1, 1990
Effect on the fetus of infusing a commercial amino acid preparation into a pregnant sheepR A MacMahon, R J Frampton, R W Yardley
Cell Biochemistry and Function|April 1, 1986
Biochemical significance of enhanced activity of fluorinated 1,25-dihydroxyvitamin D3 in human cultured cell linesJ A Eisman, R J Frampton, F J McLean
Biology of the Neonate|January 1, 1986
Changes in plasma amino acids in the developing chickR J Frampton, R W Yardley, R A MacMahon
The Australian and New Zealand Journal of Surgery|February 1, 1984
1,25-dihydroxyvitamin D3 and breast cancerJ A Eisman, L J Suva, R J Frampton
Cancer Research|September 1, 1983
Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolitesR J Frampton, S A Omond, J A Eisman
The Journal of Endocrinology|July 1, 1991
Increased secretion of insulin-like growth factor-binding proteins and decreased secretion of insulin-like growth factor-II by muscle from growth-retarded neonatal ratsR J Frampton, H A Jonas, R G Larkins
Journal of Developmental Physiology|March 1, 1990
Failure of IGF-1 to affect protein turnover in muscle from growth-retarded neonatal ratsR J Frampton, H A Jonas, R A MacMahon, et al.
Clinical Endocrinology|September 1, 1980
Normal and malignant breast tissue is a target organ for 1,25-(0H)2 vitamin D3J A Eisman, I Macintyre, T J Martin, et al.
Pageof 2